LOS ANGELES--(BUSINESS WIRE)--A scientific paper confirming the relationship between autonomic nervous
system dysfunction and Gulf War Illness was published online November
26, 2012 in the Archives of Neurology, according to Targeted
Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty
pharmaceutical company that develops and distributes prescription
medical foods to physicians and pharmacies.

“It now gives physicians a medical condition they can test for and
treat.”

“The results of this study confirm our company’s approach to the
management of Gulf War Illness and other diseases involving disordered
autonomic function,” said William Shell, M.D., CEO and chief scientific
officer of Targeted Medical Pharma, Inc., co-author of the scientific
paper who provided data, analysis, and manuscript revisions, along with
the late Elizabeth Charuvastra, RN, co-founder of Targeted Medical
Pharma. “Our company is poised to educate military and civilian
healthcare providers how to utilize the prescription-only medical foods
Sentra AM® and Sentra PM® as part of a regimen to
manage autonomic dysfunction associated with Gulf War Illness and other
chronic diseases.”

The scientific paper was primarily designed and implemented by Dr.
Robert W. Haley, chief of epidemiology at the University of Texas
Southwestern Medical Center, and Dr. Steven Vernino, chief of the
neuromuscular division at the University of Texas Southwestern Medical
Center.

“This is the first study to establish a medical basis for symptoms of
Gulf War Illness in a large, representative sample of veterans using
validated medical tests,” said Dr. Haley, principal author of the paper.
“It now gives physicians a medical condition they can test for and
treat.”

Funded by the U.S. Department of Veterans Affairs, U.S. Army Medical
Research and Material Command, and the National Institute of Health, the
study looked at 97 Gulf War-era veterans who met the standardized case
definition of Gulf War Illness. The authors of prior studies raised the
hypothesis that symptoms in veterans of the 1991 Gulf War, such as
chronic diarrhea, dizziness, fatigue, and sexual dysfunction, are due to
cholinergic autonomic dysfunction.

About Targeted Medical Pharma, Inc.’s Medical Foods

Targeted Medical Pharma’s medical foods are amino acid based,
FDA-regulated medications specially formulated to meet the body’s
increased nutritional requirements of certain disease states. They are a
safe and effective option for treating pain syndromes, sleep and
cognitive disorders, obesity, hypertension and peripheral neuropathy
without harmful side effects. These medical foods are available by
prescription only and must be administered under the ongoing supervision
of a physician.

The company recently published results from a clinical trial of its
proprietary medical food Sentra PM, which demonstrated
improved sleep latency and improved nighttime parasympathetic nervous
system activity as a standalone medication or used in conjunction with a
low dose of Trazadone. The results of the study have been published in
the May issue of the Journal of Central Nervous System Disease (http://bit.ly/SentraPM_Study).

Targeted Medical Pharma, Inc.

Targeted
Medical Pharma, Inc. is a specialty pharmaceutical company that
developsand sells prescription medical
foods to physicians and pharmacies for the treatment of chronic
disease including pain syndromes, obesity, peripheral neuropathy, sleep
and cognitive disorders. The company manufactures ten proprietary
prescription-only medical foods, as well as 48 convenience packed kits,
which pair a medical food and branded or generic pharmaceutical. These
prescription medical food products and therapeutic systems represent a
novel approach to the management of certain disease states, focusing on
safety and efficacy without the deleterious side effects of traditional,
high dose prescription drugs. Based in Los Angeles, the company’s
proprietary pharmaceutical therapeutic systems are currently sold in the
United States and the Middle East. Targeted Medical Pharma also provides
cardiac diagnostic testing services as well as billing and collection
services on behalf of dispensing physicians.

Forward Looking Statement

This press releasemay contain forward-looking statements
related to the company’s business strategy, outlook, objectives, plans,
intentions or goals. The words "may," "will," "should," "plans,"
"explores," "expects," "anticipates," "continue," "estimate," "project,"
"intend," and similar expressions, identify forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of
1995, but their absence does not mean that the statement is not
forward-looking. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties, and
assumptions that are difficult to predict. Actual results could differ
materially. Targted Medical Pharma expressly disclaim any obligation or
undertaking to update or revise any forward-looking statement contained
herein to reflect any change in the company's expectations with regard
thereto or any change in events, conditions or circumstances upon which
any statement is based.